Catalyst Wire Dossier Catalyst Wire Dossier

GLOBAFFIN

· Fresenius Medical Care Deutschland GmbH
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GLOBAFFIN, covering 2025-09-04 to 2025-09-04. Get the full timeline:

Most recent: Clinical Trial Update: Documentation of the Safety and Effectiveness Profile of the IgG Immunoadsorber GLOBAFFIN® in Clinical Routine [NA]

See pricing